---
title: "NewcelX prices USD 1.4 million private placement at USD 4.03 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294517143.md"
description: "NewcelX priced a $1.4 million private placement at $4.03 per share, a 20% premium to the July 30 close. The deal includes 347,134 common shares and warrants for an equal number of shares at a $4.44 exercise price. Proceeds will advance NCEL-101 for type 1 diabetes in partnership with Eledon Pharmaceuticals, with remaining funds for working capital. Closing is targeted for around August 14."
datetime: "2026-07-31T13:00:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294517143.md)
  - [en](https://longbridge.com/en/news/294517143.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294517143.md)
generator: "portal-rs"
---

# NewcelX prices USD 1.4 million private placement at USD 4.03 per share

-   NewcelX priced a USD 1.4 million private placement at USD 4.03 per share, a 20% premium to the July 30 close. \* Deal covers 347,134 common shares, with warrants for 347,134 shares at a USD 4.44 exercise price. \* Closing targeted for about Aug. 14, subject to customary conditions. \* Proceeds earmarked to advance NCEL-101 for type 1 diabetes, with Eledon Pharmaceuticals, with remaining funds for working capital. \* Securities to be issued in an unregistered offering under Section 4(a)(2) and Regulation D. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310900PRIMZONEFULLFEED9801621) on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [NCEL.US](https://longbridge.com/en/quote/NCEL.US.md)
- [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md)
- [NLSP.US](https://longbridge.com/en/quote/NLSP.US.md)
- [NLSPW.US](https://longbridge.com/en/quote/NLSPW.US.md)

## Related News & Research

- [Eledon Pharmaceuticals, Inc. $ELDN Shares Bought by Bank of America Corp DE](https://longbridge.com/en/news/297613112.md)
- [Scandinavian Enviro sets warrant exercise price at SEK 0.12](https://longbridge.com/en/news/297496687.md)
- [Eurofins CFO Laurent Lebras exercises 750 warrants at EUR 529.65 each](https://longbridge.com/en/news/297671907.md)
- [PMV Pharma launches underwritten public offering of common stock, warrants](https://longbridge.com/en/news/297555887.md)
- [Onar Holding retires secured convertible note, cancels warrant and 6,000,000 shares](https://longbridge.com/en/news/297653210.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**